TNFRSF8 and lymphoma: Patient VI developed CD20+ NLPHL (nodular lymphocyte predominant Hodgkin lymphoma) at 17 years of age, which in contrast to his brother’s lymphoma, was negative for CD30 and EBV antigens (Figure 1B).